Cover Image
Market Research Report

Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2022

Published by iGate Research Pvt Ltd Product code 396672
Published Content info 216 Pages
Immediate Delivery Available
Price
Back to Top
Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2022
Published: April 10, 2017 Content info: 216 Pages
Description

The global influenza vaccines market is anticipated to reach nearly US$ 5 Billion by 2022. Influenza viruses are considered as a major cause of morbidity and mortality worldwide. The vast population base together with significantly low vaccination coverage in emerging markets, rising government support for immunization and growing awareness of the value of influenza vaccine in preventing disease are the prominent factors that will fuel the growth of the influenza vaccines market.

Geographically, North America is the largest market for influenza vaccines capturing nearly 50% market share in 2016. Asia is the second largest market for influenza vaccines. Europe is the third largest market for influenza vaccines, followed by Latin America with around XX% share in 2016. Australasia accounted for least share of the influenza vaccines market in 2016.

On the basis of country, United States captures majority of the influenza vaccines market share. Japan is the second leading market for influenza vaccines with around XX% share. China and India are the third and fourth leading market for influenza vaccines with XX% and XX% market share respectively in 2016. Brazil, Germany, France, UK, Italy, Spain and South Korea are the other leading market for influenza vaccines.

In the influenza vaccines brand sales segment, Sanofi's Fluzone holds the maximum share of the market being followed by Fluvirin/Flucelvax. GSK's Fluarix/FluLaval accounts for the third highest share of the influenza vaccines market. Afluria/Fluvax and FluMist/Fluenz stands at the fourth and fifth position in the influenza vaccines market, while Flublok has captured least share of the influenza vaccines market.

This is the 3rd edition report on influenza vaccines market by iGATE Research. The report titled “Global Influenza Vaccines Market, Persons Vaccinated, Brand Analysis and Forecast to 2022” provides a comprehensive analysis of the fast-evolving influenza vaccines market. This 216 Page report contains 137 Figures and 12 Tables to present a clear picture of the influenza vaccines market landscape.

The Influenza Vaccines Market have been analyzed from 5 viewpoints:

  • 1. Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region (2011 - 2022)
  • 2. Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (2011 - 2022)
  • 3. Global - Influenza Vaccines Brand Sales and Forecast to 2022
  • 4. Global Influenza Vaccines Market - Major Deals
  • 5. Global Influenza Vaccines Market - Driving Factors and Challenges

Influenza Vaccines Market, Persons Vaccinated and Forecast - By Region

  • 1. North America
  • 2. Latin America
  • 3. Europe
  • 4. Asia
  • 5. Australasia

Influenza Vaccines Market, Persons Vaccinated and Forecast - Country Wise Distribution (25 Countries Covered)

  • 1. United States
  • 2. Canada
  • 3. Brazil
  • 4. Mexico
  • 5. Germany
  • 6. France
  • 7. Italy
  • 8. Spain
  • 9. United Kingdom
  • 10. Netherlands
  • 11. Ireland
  • 12. Denmark
  • 13. Luxembourg
  • 14. Sweden
  • 15. Australia
  • 16. New Zealand
  • 17. Japan
  • 18. China
  • 19. India
  • 20. South Korea
  • 21. Singapore
  • 22. Hong Kong
  • 23. Malaysia
  • 24. Thailand
  • 25. Indonesia

Influenza Vaccines Brand Sales and Forecast - 7 Brands Analyzed

  • 1. Fluarix/FluLaval
  • 2. Fluzone
  • 3. Fluvirin/Flucelvax
  • 4. Influvac
  • 5. Afluria/Fluvax
  • 6. FluMist/Fluenz
  • 7. Flublok

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

  • Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.
  • Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases
Table of Contents

Table of Contents

1. Executive Summary

2. Global-Influenza Vaccines Market Analysis and Forecast (2011-2022)

  • 2.1. Global-Influenza Vaccines Market and Forecast (2011-2022)
  • 2.2. Global-Number of Persons Vaccinated with Influenza Vaccines and Forecast (2011-2022)

3. Global-Influenza Vaccines Market Share Analysis and Forecast

  • 3.1. Influenza Vaccines Market Share and Forecast- Region Wise Analysis (2011-2022)
  • 3.2. Influenza Vaccines Market Share and Forecast-Country Wise Analysis (2011-2022)
  • 3.3. Persons Being Vaccinated with Influenza Vaccines Share and Forecast-Region Wise Analysis (2011-2022)
  • 3.4. Persons Being Vaccinated with Influenza Vaccines Share and Forecast-Country Wise Analysis (2011-2022)

4. Influenza Vaccines Market, Persons Vaccinated and Forecast-By Region (2011-2022)

  • 4.1. North America-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.1.1. North America-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.1.2. North America-Influenza Vaccines Market and Forecast
  • 4.2. Latin America-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.2.1. Latin America-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.2.2. Latin America-Influenza Vaccines Market and Forecast
  • 4.3. Europe-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.3.1. Europe-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.3.2. Europe-Influenza Vaccines Market and Forecast
  • 4.4. Asia-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.4.1. Asia-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.4.2. Asia-Influenza Vaccines Market and Forecast
  • 4.5. Australasia-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 4.5.1. Australasia-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 4.5.2. Australasia-Influenza Vaccines Market and Forecast

5. Influenza Vaccines Market, Persons Vaccinated and Forecast-Country Wise Distribution (2011-2022)

  • 5.1. United States-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.1.1. United States-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.1.2. United States-Influenza Vaccines Market and Forecast
  • 5.2. Canada-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.2.1. Canada-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.2.2. Canada-Influenza Vaccines Market and Forecast
  • 5.3. Brazil-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.3.1. Brazil-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.3.2. Brazil-Influenza Vaccines Market and Forecast
  • 5.4. Mexico-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.4.1. Mexico-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.4.2. Mexico-Influenza Vaccines Market and Forecast
  • 5.5. Germany-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.5.1. Germany-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.5.2. Germany-Influenza Vaccines Market and Forecast
  • 5.6. France-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.6.1. France-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.6.2. France-Influenza Vaccines Market and Forecast
  • 5.7. Italy-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.7.1. Italy-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.7.2. Italy-Influenza Vaccines Market and Forecast
  • 5.8. Spain-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.8.1. Spain-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.8.2. Spain-Influenza Vaccines Market and Forecast
  • 5.9. United Kingdom-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.9.1. United Kingdom-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.9.2. United Kingdom-Influenza Vaccines Market and Forecast
  • 5.10. Netherlands-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.10.1. Netherlands-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.10.2. Netherlands-Influenza Vaccines Market and Forecast
  • 5.11. Ireland-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.11.1. Ireland-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.11.2. Ireland-Influenza Vaccines Market and Forecast
  • 5.12. Denmark-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.12.1. Denmark-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.12.2. Denmark-Influenza Vaccines Market and Forecast
  • 5.13. Luxembourg-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.13.1. Luxembourg-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.13.2. Luxembourg-Influenza Vaccines Market and Forecast
  • 5.14. Sweden-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.14.1. Sweden-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.14.2. Sweden-Influenza Vaccines Market and Forecast
  • 5.15. Australia-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.15.1. Australia-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.15.2. Australia-Influenza Vaccines Market and Forecast
  • 5.16. New Zealand-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.16.1. New Zealand-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.16.2. New Zealand-Influenza Vaccines Market and Forecast
  • 5.17. Japan-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.17.1. Japan-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.17.2. Japan-Influenza Vaccines Market and Forecast
  • 5.18. China-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.18.1. China-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.18.2. China-Influenza Vaccines Market and Forecast
  • 5.19. India-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.19.1. India-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.19.2. India-Influenza Vaccines Market and Forecast
  • 5.20. South Korea-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.20.1. South Korea-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.20.2. South Korea-Influenza Vaccines Market and Forecast
  • 5.21. Thailand-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.21.1. Thailand-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.21.2. Thailand-Influenza Vaccines Market and Forecast
  • 5.22. Singapore-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.22.1. Singapore-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.22.2. Singapore-Influenza Vaccines Market and Forecast
  • 5.23. Hong Kong-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.23.1. Hong Kong-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.23.2. Hong Kong-Influenza Vaccines Market and Forecast
  • 5.24. Malaysia-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.24.1. Malaysia-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.24.2. Malaysia-Influenza Vaccines Market and Forecast
  • 5.25. Indonesia-Influenza Vaccines Market, Persons Vaccinated and Forecast
    • 5.25.1. Indonesia-Number of Persons Vaccinated with Influenza Vaccines and Forecast
    • 5.25.2. Indonesia-Influenza Vaccines Market and Forecast

6. Global-Influenza Vaccines Brand Sales and Forecast

  • 6.1. Global-Fluarix / FluLaval Sales and Forecast (2007-2022)
  • 6.2. Global-Fluzone Sales and Forecast (2009-2022)
  • 6.3. Global-Fluvirin/Flucelvax Sales and Forecast (2010-2022)
  • 6.4. Global-Influvac (Acquired by Abbott) Sales (2007-2009)
  • 6.5. Global-Afluria/Fluvax Sales and Forecast (2010-2022)
  • 6.6. Global-FluMist/Fluenz Sales and Forecast (2007-2022)
  • 6.7. Global-Flublok Sales and Forecast (2013-2022)

7. Influenza Vaccines Market-Major Deals

  • 7.1. Mergers and Acquisitions
  • 7.2. Licensing Agreements

8. Global Influenza Vaccines Market-Driving Factors

  • 8.1. Transformation of Vaccine Technologies
  • 8.2. Vaccines most Cost Effective Means of Disease Prevention
  • 8.3. Scientific & Technological Breakthroughs
  • 8.4. Continuous Focus on Effective Communication Strategies
  • 8.5. Increasing Awareness on Seasonal Influenza & Vaccination

9. Global Influenza Vaccines Market-Challenges

  • 9.1. Complexity of Vaccine Development and Approval System Thwarts Product Development
    • 9.1.1. Legal Obstacles
    • 9.1.2. General Technical Barriers
    • 9.1.3. Economic Barriers
    • 9.1.4. Regulatory Barriers
  • 9.2. Hurdles to Optimal use of Licensed Vaccines
    • 9.2.1. Technical Obstacles
    • 9.2.2. Economic obstacles
    • 9.2.3. Cultural Obstacles
  • 9.3. Barriers to New Entrants in the Vaccines Market
  • 9.4. Reducing the Timeline for Vaccine Development
  • 9.5. Challenges Faced by Healthcare Workers in Immunization

List of Figures:

  • Figure 2-1: Global-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 2-2: Global-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 2-3: Global-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 2-4: Global-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 4-1: North America-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 4-2: North America-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 4-3: North America-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 4-4: North America-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 4-5: Latin America-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 4-6: Latin America-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 4-7: Latin America-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 4-8: Latin America-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 4-9: Europe-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 4-10: Europe-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 4-11: Europe-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 4-12: Europe-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 4-13: Asia-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 4-14: Asia-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 4-15: Asia-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 4-16: Asia-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 4-17: Australasia-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 4-18: Australasia-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 4-19: Australasia-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 4-20: Australasia-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-1: United States-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-2: United States-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-3: United States-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-4: United States-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-5: Canada-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-6: Canada-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-7: Canada-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-8: Canada-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-9: Brazil-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-10: Brazil-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-11: Brazil-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-12: Brazil-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-13: Mexico-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-14: Mexico-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-15: Mexico-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-16: Mexico-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-17: Germany-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-18: Germany-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-19: Germany-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-20: Germany-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-21: France-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-22: France-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-23: France-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-24: France-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-25: Italy-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-26: Italy-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-27: Italy-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-28: Italy-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-29: Spain-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-30: Spain-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-31: Spain-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-32: Spain-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-33: United Kingdom-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-34: United Kingdom-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-35: United Kingdom-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-36: United Kingdom-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-37: Netherlands-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-38: Netherlands-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-39: Netherlands-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-40: Netherlands-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-41: Ireland-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-42: Ireland-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-43: Ireland-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-44: Ireland-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-45: Denmark-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-46: Denmark-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-47: Denmark-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-48: Denmark-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-49: Luxembourg-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-50: Luxembourg-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-51: Luxembourg-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-52: Luxembourg-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-53: Sweden-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-54: Sweden-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-55: Sweden-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-56: Sweden-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-57: Australia-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-58: Australia-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-59: Australia-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-60: Australia-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-61: New Zealand-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-62: New Zealand-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-63: New Zealand-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-64: New Zealand-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-65: Japan-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-66: Japan-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-67: Japan-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-68: Japan-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-69: China-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-70: China-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-71: China-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-72: China-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-73: India-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-74: India-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-75: India-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-76: India-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-77: South Korea-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-78: South Korea-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-79: South Korea-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-80: South Korea-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-81: Thailand-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-82: Thailand-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-83: Thailand-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-84: Thailand-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-85: Singapore-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-86: Singapore-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-87: Singapore-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-88: Singapore-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-89: Hong Kong-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011 - 2016
  • Figure 5-90: Hong Kong-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-91: Hong Kong-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-92: Hong Kong-Forecast for Influenza Vaccines Market (Million US$), 2017 - 2022
  • Figure 5-93: Malaysia-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-94: Malaysia-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-95: Malaysia-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-96: Malaysia-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 5-97: Indonesia-Number of Persons Vaccinated with Influenza Vaccines (Million), 2011-2016
  • Figure 5-98: Indonesia-Forecast for Number of Persons Vaccinated with Influenza Vaccines (Million), 2017-2022
  • Figure 5-99: Indonesia-Influenza Vaccines Market (Million US$), 2011-2016
  • Figure 5-100: Indonesia-Forecast for Influenza Vaccines Market (Million US$), 2017-2022
  • Figure 6-1: Global-Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2007-2016
  • Figure 6-2: Global-Forecast for Fluarix / Flulaval Influenza Vaccine Sales (Million US$), 2017-2022
  • Figure 6-3: Global-Fluzone Influenza Vaccine Sales (Million US$), 2009-2016
  • Figure 6-4: Global-Forecast for Fluzone Influenza Vaccine Sales (Million US$), 2017-2022
  • Figure 6-5: Global-Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2009-2016
  • Figure 6-6: Global-Forecast for Fluvirin/Flucelvax Influenza Vaccine Sales (Million US$), 2017-2022
  • Figure 6-7: Global-Influvac Influenza Vaccine Sales (Million US$), 2007-2009
  • Figure 6-8: Global-Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2010-2016
  • Figure 6-9: Global-Forecast for Afluria/Fluvax Influenza Vaccine Sales (Million US$), 2017-2022
  • Figure 6-10: Global-FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2007-2016
  • Figure 6-11: Global-Forecast for FluMist/Fluenz Influenza Vaccine Sales (Million US$), 2017-2022
  • Figure 6-12: Global-Flublok Influenza Vaccine Sales (Million US$), 2013-2016
  • Figure 6-13: Global-Forecast for Flublok Influenza Vaccine Sales (Million US$), 2017-2022

List of Tables:

  • Table 3-1: Region Wise-Influenza Vaccines Market Share (Percent), 2011-2016
  • Table 3-2: Region Wise-Forecast for Influenza Vaccines Market Share (Percent), 2017-2022
  • Table 3-3: Country Wise-Influenza Vaccines Market Share (Percent), 2011-2016
  • Table 3-4: Country Wise-Forecast for Influenza Vaccines Market Share (Percent), 2017-2022
  • Table 3-5: Region Wise-Persons Vaccinated with Influenza Vaccines Share (Percent), 2011-2016
  • Table 3-6: Region Wise-Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2017-2022
  • Table 3-7: Country Wise-Persons Vaccinated with Influenza Vaccines Share (Percent), 2011-2016
  • Table 3-8: Country Wise-Forecast for Persons Vaccinated with Influenza Vaccines Share (Percent), 2017-2022
  • Table 7-1: Global-Mergers and Acquisitions in Influenza Vaccines Market (Million US$), 2005-2015
  • Table 7-2: Global-Licensing Agreement in Influenza Vaccines Market (Million US$), 2007-2015
  • Table 8-1: Improvement Strategies or Requirements-the Joint Commission and the Project's Collaborating Organizations
  • Table 8-2: Initiatives Taken in Communication, Education, Training & Information Exchange Related to Seasonal Influenza in European Countries, 2009
Back to Top